Benjamin Arrants, MS, MBA

Benjamin Arrants, MS, MBA has a diverse work experience in the biotech and oncology fields. From 2022 to present, they have been working as a Biotech Market Research Analyst at Slingshot Insights. From 2020 to 2021, they worked as a Clinical Oncology Analyst at Sarah Cannon Research Institute. From 2019 to 2020, they were a Clinical Trial Consultant - Biotech at DAVA Oncology, where they provided strategic clinical trial consulting for phase I-III Oncology studies. This included conducting primary and secondary research through sponsor engagement and clinical team interviews, forming relationships with Key Opinion Leaders (KOLs), performing in-person site visits with investigators and study staff, and organizing and designing trial-specific study teleconferences.

Benjamin Arrants has an extensive education history. Benjamin completed a Bachelor of Arts in Biology from the University of Kentucky in 2018. Following this, they went on to obtain a Master of Business Administration from the University of Kentucky in 2019. Most recently, they obtained a Master's degree in Molecular Biology from Lipscomb University in 2021. In addition to their academic qualifications, they also hold multiple certifications, including a Clinical Research Professional Development Program from Kriger Research Group International, a Lean Six Sigma Green Belt from Analytical Center LEANCOR Inc., a Design and Interpretation of Clinical Trials from Coursera, a Drug Discovery from Coursera, a Data Management for Clinical Research from Coursera, a Certified Associate in Project Management (CAPM) from Project Management Institute, and a Certification in Clinical Healthcare Management and Health Communication from the University of Kentucky.